Proteomic Analysis of Src Family Kinase Phosphorylation States in Cancer Cells Suggests Deregulation of the Unique Domain
Ana Ruiz-Sáenz(CIC bioGUNE), Mark M. Moasser(University of California, San Francisco)
Cited by 14
Related Papers
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
|Nature|2007|991
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver
|Science Translational Medicine|2010|185
A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition
|Biochemical Journal|2008|125
A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF <sup>V600E</sup> colorectal tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0
Metabolic Alterations driven by PFKFB3 upregulation confer Resistance to Trastuzumab in HER2-Positive Breast Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0